Cancer-Associated Thrombosis: A New Light on an Old Story
Cancer-associated thrombosis (CAT) is a rising and significant phenomenon, becoming the second leading cause of death in cancer patients. Pathophysiology of CAT differs from thrombosis in the non-cancer population. There are additional risk factors for thrombosis specific to cancer including cancer...
Main Authors: | Sidrah Shah, Afroditi Karathanasi, Antonios Revythis, Evangelia Ioannidou, Stergios Boussios |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/9/2/34 |
Similar Items
-
Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
by: Zygimantas Zaboras, et al.
Published: (2024-01-01) -
Dual direct oral anticoagulant therapy in challenging thrombosis: a case series
by: Nicholas L.J. Chornenki, et al.
Published: (2024-08-01) -
Cancer-associated thrombosis: A meta-analysis and single-center experience
by: Hakkı Tankut Akay, et al.
Published: (2022-03-01) -
Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01) -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
by: Mehrie H. Patel, et al.
Published: (2024-05-01)